Lancet 394:131138 Tuttle KR, Lakshmanan MC, Rayner B, Busch RS, Zimmermann AG, Woodward DB et al (2018) Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
12 It is also worth situating retatrutide within the broader arc of metabolic peptide development rather than treating it as a standalone novelty
Pregnancy and Breastfeeding: Safe under medical supervision, but consult your doctor before use
By reaching a threshold of 2530g of protein early in the day, you satisfy the Protein Leverage Hypothesis, which states the body will continue to signal hunger until its amino acid requirements are met
Whether it's the right option for you depends on your health situation, financial circumstances, risk tolerance, and comfort with the compounded medication framework